Anna Petoukhova

Dr. Anna Petoukhova

Haaglanden Medical Center, Department of Medical Physics, Leidschendam, The Netherlands

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2013 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
MMMirjam E. Mast
Mirjam E. Mast
LKLoes van Kempen-Harteveld
Loes van Kempen-Harteveld
MHMark W. Heijenbrok
Mark W. Heijenbrok
YKYamoena Kalidien
Yamoena Kalidien
HRHans Rozema
Hans Rozema
HSHenk Struikmans
Henk Struikmans

1 October 2014 in Breast Cancer Research and Treatment
Verified
Journal Article
Open access
PDF file
MMMirjam E. Mast
Mirjam E. Mast
EVEline J. Vredeveld
Eline J. Vredeveld
HCHerman M. Credoe
Herman M. Credoe
JEJaap van Egmond
Jaap van Egmond
MHMark W. Heijenbrok
Mark W. Heijenbrok
JMJohn H. Maduro
John H. Maduro
Purpose In left-sided breast cancer radiotherapy, tangential intensity modulated radiotherapy combined with breath-hold enables a dose reduction to the heart and left anterior descending (LAD) coronary artery. Aim of this study was to investigate the added value of intensity modulated proton therapy (IMPT) with regard to decreasing the radiation dose to these structures. Methods In this comparative planning study, four treatment plans were generated in 20 patients: an IMPT plan and a tangential IMRT plan, both with breath-hold and free-breathing. At least 97 % of the target volume had to be covered by at least 95 % of the prescribed dose in all cases. Specifically with respect to the heart, the LAD, and the target volumes, we analyzed the maximum doses, the mean doses, and the volumes receiving 5–30 Gy. Results As compared to IMRT, IMPT resulted in significant dose reductions to the heart and LAD-region even without breath-hold. In the majority of the IMPT cases, a reduction to almost zero to the heart and LAD-region was obtained. IMPT treatment plans yielded the lowest dose to the lungs. Conclusions With IMPT the dose to the heart and LAD-region could be significantly decreased compared to tangential IMRT with breath-hold. The clinical relevance should be assessed individually based on the baseline risk of cardiac complications in combination with the dose to organs at risk. However, as IMPT for breast cancer is currently not widely available, IMPT should be reserved for patients remaining at high risk for major coronary events.

1 August 2020 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
GFGerd Fastner
Gerd Fastner
CGChristoph Gaisberger
Christoph Gaisberger
JKJulia Kaiser
Julia Kaiser
PSPhilipp Scherer
Philipp Scherer
ACAntonella Ciabattoni
Antonella Ciabattoni
MLMaria Cristina Leonardi
Maria Cristina Leonardi

1 January 2005 in Microvascular Research
Verified
Journal Article
Closed access
FMFernando Morales
Fernando Morales
RGReindert Graaff
Reindert Graaff
ASAndries J. Smit
Andries J. Smit
SBSilvia Bertuglia
Silvia Bertuglia
APAnna Petoukhova
Anna Petoukhova
GRGerhard Rakhorst
Gerhard Rakhorst

1 March 2012 in International Journal of Radiation Oncology, Biology, Physics
Verified
Journal Article
Closed access
MGMarina Giezen
Marina Giezen
EKErik Kouwenhoven
Erik Kouwenhoven
ASAstrid N. Scholten
Astrid N. Scholten
ECEmile G. Coerkamp
Emile G. Coerkamp
MHMark Heijenbrok
Mark Heijenbrok
HSHenk Struikmans
Henk Struikmans

1 January 2020 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
MFMireille A. Florijn
Mireille A. Florijn
ASAbdul Wahab M. Sharfo
Abdul Wahab M. Sharfo
RWRuud G.J. Wiggenraad
Ruud G.J. Wiggenraad
JSJan P.C. van Santvoort
Jan P.C. van Santvoort
APAnna Petoukhova
Anna Petoukhova
MDMaarten L.P. Dirkx
Maarten L.P. Dirkx